As of December 2022, the generics major has 338 approvals and filed over 431 ANDAs since the commencement of the filing process in fiscal year 2003-04.
Zydus has manufacturing sites and research facilities spread across five Indian states (Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim) as well as in the US and Brazil.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze